On this episode of the ⁠Administrative Law Review’s A Hard Look⁠, tune in to listen to our Senior Technology Editor, ⁠Alexander Naum⁠ speak with Lauren Saxe, a rising 2L at American University Washington College of Law and ALR's incoming Senior Symposia & Communications Editor. In this episode, we review the regulatory framework surrounding FDA’s approval of Mifepristone in 2000. Including reviewing and questioning its REMS status by the Agency. As well as analyzing how the Supreme Court’s ruling in Dobbs has limited access to this medication. And how recent and pending federal jurisprudence can potentially jeopardize nationwide access to this medication for patients seeking access to abortion and miscarriage treatment.

If you have any questions about this episode, the guest, or the podcast, or if you would like to propose a topic or a guest, please email Bennett Nuss at [email protected]